New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu
Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer!
Herbal Remedies For Insomnia
Cutting-edge 'peptide' shows promise in stopping breast cancer metastasis!
